Form 4: Health Catalyst CFO Executes Sell-to-Cover Transaction

Health Catalyst CFO Jason Alger sold 18,804 shares to satisfy tax withholding obligations related to RSU vesting.

Summary

• Chief Financial Officer Jason Alger disposed of 18,804 shares of Health Catalyst, Inc. (HCAT) common stock.
• The transaction occurred on June 1, 2026, at a price of $1.3702 per share.
• Following this transaction, the reporting person maintains beneficial ownership of 722,840 shares.
• The sale was a mandatory 'sell-to-cover' transaction to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative transaction related to tax obligations rather than a discretionary market move.

Positives

• The transaction was non-discretionary and mandated by the company's equity incentive plan requirements.

Negatives

• The transaction reflects a reduction in the direct equity stake held by the CFO, albeit for tax purposes.

Risks

• The stock price of $1.3702 reflects current market valuation levels for the issuer.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Management Comments

• The sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

StockSavvy.ai notes that sell-to-cover transactions are standard administrative procedures for corporate executives to manage tax liabilities associated with equity compensation vesting and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The use of 'sell-to-cover' mechanisms is a standard practice among U.S. publicly traded companies to manage RSU tax withholding.
• The transaction aligns with typical executive compensation governance protocols.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary and related to tax compliance.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Health Catalyst, HCAT, Insider Trading, Form 4, CFO, Equity Compensation